Suppr超能文献

口服微囊化镁(MAGSHAPE微囊)与其他镁源后镁吸收及副作用的比较临床研究。

Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPE Microcapsules) Versus Other Magnesium Sources.

作者信息

Pajuelo David, Meissner Justyna M, Negra Teresa, Connolly Alan, Mullor Jose L

机构信息

Bionos Biotech SL, LabAnalysis Life Science, Biopolo Hospital La Fe, 46026 Valencia, Spain.

Lubrizol Life Science, 08850 Gavà, Spain.

出版信息

Nutrients. 2024 Dec 18;16(24):4367. doi: 10.3390/nu16244367.

Abstract

BACKGROUND/OBJECTIVES: Magnesium (Mg)-based food supplements contribute to the maintenance of adequate levels of Mg that are essential for overall health and well-being. The aim of this double-blind, randomized, cross-over clinical study was to assess the plasma Mg levels in volunteers following the oral administration of a magnesium-based nutraceutical ingredient, MAGSHAPE microcapsules (Mg-MS), in comparison to other commonly used magnesium sources, including the following: Mg Oxide (MgO), Mg Citrate (Mg-C), and Mg bisglycinate (Mg-BG).

METHODS

A total of 40 healthy women and men were put on a low-Mg diet for 7 days, and after 8 h of fasting, a blood sample was taken from a digital puncture before (0 h) and 1 h, 4 h, and 6 h after the oral intake of each product.

RESULTS

Our results showed that the blood plasma levels of Mg increased significantly at all tested time-points after the oral intake of Mg-MS, while the blood plasma levels of Mg increased significantly only after 1 and 4 h of the oral intake of MgO and Mg-C, respectively. However, no significant increase in Mg levels was observed upon the intake of Mg-BG. Interestingly, the Mg-MS microencapsulation technology was observed to enable a sustained increase in plasma Mg levels over the duration of this study, i.e., 1, 4, and 6 h after oral intake. A direct comparison of the increase in plasma Mg levels over the 6 h period revealed that the Mg-MS microencapsulation technology significantly increased Mg bioavailability compared to the non-microencapsulated MgO. Our study also showed that, compared to the other Mg sources tested, the Mg-MS microencapsulation technology reduced adverse side effects commonly associated with Mg supplementation, specifically with regard to increased intestinal motility and sensations of gastric heaviness following oral administration.

CONCLUSIONS

Altogether, this clinical study introduced MAGSHAPE microcapsules as a bioavailable and well-tolerated alternative to existing Mg-based ingredients used in food supplements.

摘要

背景/目的:镁(Mg)基食品补充剂有助于维持足够的镁水平,这对整体健康和幸福至关重要。这项双盲、随机、交叉临床研究的目的是评估志愿者口服一种镁基营养成分MAGSHAPE微胶囊(Mg-MS)后血浆镁水平,并与其他常用镁源进行比较,这些镁源包括:氧化镁(MgO)、柠檬酸镁(Mg-C)和甘氨酸镁(Mg-BG)。

方法

总共40名健康女性和男性进行为期7天的低镁饮食,禁食8小时后,在口服每种产品前(0小时)以及口服后1小时、4小时和6小时通过指尖采血采集血样。

结果

我们的结果显示,口服Mg-MS后,在所有测试时间点血浆镁水平均显著升高,而口服MgO和Mg-C后,血浆镁水平分别仅在1小时和4小时后显著升高。然而,口服Mg-BG后未观察到镁水平显著升高。有趣的是,在本研究期间,即口服后1小时、4小时和6小时,观察到Mg-MS微胶囊技术能使血浆镁水平持续升高。对6小时内血浆镁水平升高情况的直接比较显示,与未微胶囊化的MgO相比,Mg-MS微胶囊技术显著提高了镁的生物利用度。我们的研究还表明,与其他测试的镁源相比,Mg-MS微胶囊技术减少了与镁补充剂常见的不良副作用,特别是口服后肠道蠕动增加和胃部沉重感。

结论

总之,这项临床研究引入了MAGSHAPE微胶囊,作为食品补充剂中现有镁基成分的一种生物可利用且耐受性良好的替代品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/11677548/ea7f0f841ca1/nutrients-16-04367-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验